ARVN
Arvinas Inc
NASDAQ: ARVN · HEALTHCARE · BIOTECHNOLOGY
$9.90
+0.81% today
Updated 2026-04-30
Market cap
$667.75M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-1.14
Dividend yield
—
52W range
$6 – $15
Volume
0.9M
Arvinas Inc (ARVN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+30.1%
Last 4 quarters
Revenue YoY growth
-84.0%
Most recent quarter
EPS YoY growth
-74.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+0.7%
2026-03-02
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $-1.10 | -122.0% | $13.27 | $13.36 | +0.7% |
| 2025-10-28 | $-0.48 | +36.8% | $9.65 | $9.59 | -0.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.50 | $-1.10 | -122.0% | $9.50M | -84.0% |
| 2025-09-30 | $-0.76 | $-0.48 | +36.8% | $41.90M | -59.1% |
| 2025-06-30 | $-0.89 | $-0.84 | +5.6% | $22.40M | -70.7% |
| 2025-03-31 | $-0.97 | $1.14 | +217.5% | $188.80M | +646.2% |
| 2024-12-31 | $-0.96 | $-0.63 | +34.4% | $59.20M | -237.4% |
| 2024-09-30 | $-0.87 | $-0.68 | +21.8% | $102.40M | +196.0% |
| 2024-06-30 | $-0.86 | $-0.49 | +43.0% | $76.50M | +40.4% |
| 2024-03-31 | $-1.42 | $-0.97 | +31.7% | $25.30M | -22.2% |
| 2023-12-31 | $-1.27 | $-2.53 | -99.2% | $-43.10M | — |
| 2023-09-30 | $-1.58 | $-1.18 | +25.3% | $34.60M | — |
| 2023-06-30 | $-1.65 | $-1.25 | +24.2% | $54.50M | — |
| 2023-03-31 | $-1.51 | $-1.54 | -2.0% | $32.50M | — |
| 2022-12-31 | $-1.22 | $-1.56 | -27.9% | — | — |
Frequently asked questions
Has Arvinas Inc beaten earnings estimates?
Arvinas Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +30.1% over the last 4 quarters.
How does ARVN stock react to earnings?
ARVN stock has moved an average of +0.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Arvinas Inc's revenue growth rate?
Arvinas Inc reported year-over-year revenue growth of -84.0% in its most recent quarter, with EPS growing -74.6% year-over-year.